Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q6PAL8

Entry ID Method Resolution Chain Position Source
3CWZ X-ray 320 A B 707-1090 PDB
AF-Q6PAL8-F1 Predicted AlphaFoldDB

39 variants for Q6PAL8

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388931707 63 N>K No EVA
rs3388937912 101 P>L No EVA
rs3388940545 118 H>Q No EVA
rs3388897381 122 I>F No EVA
rs3388917329 130 T>I No EVA
rs3388921085 131 F>I No EVA
rs3388937915 133 F>S No EVA
rs3388941955 137 F>I No EVA
rs3388940266 149 A>S No EVA
rs3388921114 164 L>P No EVA
rs3388936596 166 A>P No EVA
rs3388937889 173 D>N No EVA
rs3388940713 180 G>S No EVA
rs3388937861 198 R>W No EVA
rs3388943852 207 I>V No EVA
rs246992150 220 R>W No EVA
rs3388940271 276 T>A No EVA
rs3388941934 427 H>L No EVA
rs3388921168 460 Y>H No EVA
rs3388927171 486 L>M No EVA
rs3398386993 493 S>C No EVA
rs3388936597 495 N>Y No EVA
rs3388943781 496 K>* No EVA
rs3388934004 529 A>V No EVA
rs3388940723 556 D>E No EVA
rs3388937916 599 P>T No EVA
rs3388940686 665 Y>* No EVA
rs3388940237 703 K>M No EVA
rs3388937723 735 L>Q No EVA
rs3388940695 743 I>N No EVA
rs3412695445 753 G>S No EVA
rs3388943791 809 Q>H No EVA
rs3388937713 934 L>M No EVA
rs3388910860 1085 S>F No EVA
rs3388940732 1158 P>S No EVA
rs3388942016 1184 D>E No EVA
rs3388931711 1190 N>K No EVA
rs3388940523 1244 T>S No EVA
rs3388942005 1284 G>C No EVA

No associated diseases with Q6PAL8

9 regional properties for Q6PAL8

Type Name Position InterPro Accession
domain SH3 domain 9 - 70 IPR001452
domain C2 DOCK-type domain 421 - 617 IPR027007
domain DOCKER domain 1207 - 1617 IPR027357
domain Dedicator of cytokinesis, N-terminal domain 73 - 416 IPR032376
domain DOCKER, Lobe A 1202 - 1330 IPR046769
domain DOCKER, Lobe B 1388 - 1469 IPR046770
domain DOCKER, Lobe C 1508 - 1610 IPR046773
domain Dedicator of cytokinesis protein 1/5, SH3 domain 13 - 68 IPR047025
domain Dedicator of cytokinesis protein 1, C2 domain 424 - 619 IPR047026

Functions

Description
EC Number
Subcellular Localization
  • Golgi apparatus membrane
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
retromer complex A conserved hetero-pentameric membrane-associated complex involved in retrograde transport from endosomes to the Golgi apparatus. The budding yeast retromer comprises Vps35p, Vps29p, Vps26p, Vps5p, and Vps17p. The mammalian complex shows slight variation in composition compared to yeast, and comprises SNX1 or SNX2, SNX5 or SNX6, VPS26A or VPS26B, VPS29, and VPS35.
trans-Golgi network The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.

2 GO annotations of molecular function

Name Definition
guanyl-nucleotide exchange factor activity Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions.
small GTPase binding Binding to a small monomeric GTPase.

2 GO annotations of biological process

Name Definition
negative regulation of neuron projection development Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
retrograde transport, endosome to Golgi The directed movement of membrane-bounded vesicles from endosomes back to the trans-Golgi network where they are recycled for further rounds of transport.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O95248 SBF1 Myotubularin-related protein 5 Homo sapiens (Human) PR
Q6ZUT9 DENND5B DENN domain-containing protein 5B Homo sapiens (Human) PR
Q6IQ26 DENND5A DENN domain-containing protein 5A Homo sapiens (Human) PR
A2RSQ0 Dennd5b DENN domain-containing protein 5B Mus musculus (Mouse) PR
10 20 30 40 50 60
MSGGGGGGGS APSRFADYFV ICGLDTETGL EPDELSALCQ YIQASKARDG ASPFISSTTE
70 80 90 100 110 120
GENFEQTPLR RTFKSKVLAR YPENVDWNPF DQDAVGMLCM PKGLAFKTQA DPREPQFHAF
130 140 150 160 170 180
IITREDGSRT FGFALTFYEE VTSKQICSAM QTLYHMHNAE YDVLHAPLAD GGDQSGMEDG
190 200 210 220 230 240
EGIPGTKLQR FNSYDISRDT LYVSKCICLI TPMSFMKACR SVLQQLHQAV TSPQPPPLPL
250 260 270 280 290 300
ESYIYNVLYE VPLPPPGRSL KFSGVYGPII CQRPSTNELP LFDFPVKEVF ELLGVENVFQ
310 320 330 340 350 360
LFTCALLEFQ ILLYSQHYQR LMTVAETITA LMFPFQWQHV YVPILPASLL HFLDAPVPYL
370 380 390 400 410 420
MGLHSNGLDD RSKLELPQEA NLCFVDVDNH FIELPEDLPQ FPNKLEFVQE VSEILMAFGV
430 440 450 460 470 480
PPEGNLHCSE SASKLKRIRA SELVSDKRNG NIAGSPLHSY ELLKENETIA RLQALVKRTG
490 500 510 520 530 540
VSLEKLEVRE DPSSNKDFKV QCDEEELRIY QLNIQIREVF ANRFTQMFAD YEVFVIQPSQ
550 560 570 580 590 600
DKESWFTNRE QMQNFDKASF LSDQPEPYLP FLSRFLETQM FASFIDNKIM CHDDDDKDPV
610 620 630 640 650 660
LRVFDSRVDK IRLLNVRTPT LRTSMYQKCT TVDEAEKAIE LRLAKIDHTA VHPHLLDMKI
670 680 690 700 710 720
GQGKYEPGFF PKLQSDVLCT GPASNKWTKR NAPAQWRRKD RQKQHTEHLR LDNDQREKYI
730 740 750 760 770 780
QEARNMGSTI RQPKLSNLSP SVIAQTNWKF VEGLLKECRN KTKRMLVEKM GREAVELGHG
790 800 810 820 830 840
EVNITGVEEN TLIASLCDLL ERIWSHGLQV KQGKSALWSH LLHYQENRQR KLTSGSLSTS
850 860 870 880 890 900
GILLDSERRK SDASAVMSPL RISLIQDMRH IQNIGEIKTD VGKARAWVRL SMEKKLLSRH
910 920 930 940 950 960
LKQLLSDHEL TKKLYKRYAF LRCDDEKEQF LYHLLSFNAV DYFCFTNVFT TILIPYHILI
970 980 990 1000 1010 1020
VPSKKLGGSM FTANPWICIS GELGETQILQ IPRNVLEMTF ECQNLGKLTT VQIGHDNSGL
1030 1040 1050 1060 1070 1080
YAKWLVECVM VRNEVTGHTY KFPCGRWLGK GMDDGSLERV LVGELLTSLP EVDERPCRTP
1090 1100 1110 1120 1130 1140
PLQQSPSVIR RLVTISPNNK PKLNTGQIQE SIGEAVNGIV KHFHKPEKER GSLTLLLCGE
1150 1160 1170 1180 1190 1200
CGLVSALEQA FQHGFKSPRL FKNVFIWDFL EKAQTYYETL EQNDVVPEEN WHTRARNFCR
1210 1220 1230 1240 1250 1260
FVTAVNNTPR NIGKDGKFQM LVCLGARDHL LHHWIALLAD CPITAHMYED VALIKDHTLV
1270 1280
NSLIRVLQTL QEFNITLDTS LVKGIDI